SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is surging on reports of a groundbreaking partnership with Novo Nordisk to sell obesity drugs, ending a prior feud. This unexpected alliance, announced late Friday, has fueled immense speculation about a massive short squeeze, leaving a highly shorted float vulnerable and sparking widespread bullish sentiment.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull (BULL) is trending after reporting strong Q4 and full-year revenue and customer asset growth, despite an EPS miss attributed to increased growth investments. Community sentiment is deeply divided, with many citing deep undervaluation and significant institutional buying, while others criticize management for sustained price declines and concerns over dilution.

SHP ETF Trust - FIS Biblically Responsible Risk Managed ETF

The $PRAY ETF is trending as widespread community discussion centers on the intersection of faith, biblical principles, and financial decision-making, directly reflecting its "Biblically Responsible" investment strategy. Users are engaging in conversations about ethical investing, seeking divine guidance in wealth management, and debating the morality of various market practices.

Rich Sparkle Holdings Ltd. engages in the provision of financial printing and corporate services. The firm offers typesetting, proofreading, translation, design, and printing of listing documents, financial reports, fund documents, circulars, and announcements. It also delivers advisory services, such as conducting internal control assessment and environmental, social and governance performance evaluation, and other services including provision of co-working space. The company was founded in 2016 and is headquartered in Hong Kong.

Rich Sparkle Holdings Ltd.

Rich Sparkle Holdings Limited

Rich Sparkle Holdings (ANPA) is seeing significant action after its acquisition of TikTok icon Khaby Lame's core company, sparking intense speculative interest due to its low float and high insider ownership, as traders weigh massive short squeeze potential against sharp warnings of a pump-and-dump.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending as the community debates the immediate impact of its new CFO hire and strong Miplyffa sales ahead of anticipated Q4 earnings and crucial EMA approval, all while navigating a complex lawsuit and persistent M&A speculation. Investors are closely watching if these catalysts can finally translate into sustained shareholder value for the rare disease focused biotech.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure is trending significantly as the community anticipates a more favorable regulatory environment for its gene therapies following Dr. Vinay Prasad's upcoming departure from the FDA, sparking widespread discussion about a potential 'softball' path forward for its Huntington's disease treatment and fueling speculation of a short squeeze.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is buzzing as the CEO's recent discussion of 'curative outcomes' for its AML therapies drives community speculation of groundbreaking REGAL trial data and a potential buyout, intensified by an ongoing AML conference and growing short squeeze chatter.

United Airlines Holdings, Inc. is a holding company, which engages in the provision of transportation services. It operates through the following geographical segments: Domestic, Atlantic, Pacific, and Latin America. The company was founded on December 30, 1968 and is headquartered in Chicago, IL.

United Airlines Holdings Inc

United Airlines is trending as its CEO warns of a significant Q1 earnings impact from surging jet fuel prices, a direct result of Middle East geopolitical tensions. Despite strong passenger demand, the community is divided between those fearing further declines due to fuel costs and others buying the dip, anticipating a rebound.

Permian Resources Holdings, Inc. engages in the exploration and production of oil and natural gas. It also focuses on driving sustainable returns through the responsible acquisition, optimization, and development of crude oil. The company was founded on October 6, 2014 and is headquartered in Midland, TX.

Permian Resources Holdings Inc. - Ordinary Shares - Class A

Permian Resources Corp - Ordinary Shares - Class A

Permian Resources is trending as crude oil prices remain elevated above $90 due to ongoing geopolitical tensions, prompting community discussion about the stock's perceived undervaluation. Investors are also actively weighing potential M&A, either with PR acquiring new assets or becoming a takeover target itself, further fueled by its strong operational performance.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is trending following robust full-year earnings that showcased record revenue, improved profitability, and a substantial AI infrastructure pipeline, sparking community discussions about its perceived undervaluation and market dynamics amidst a challenging small-cap environment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The test uses the company’s digital platform with GRAIL’s advanced cancer screening technology.</li><li>The multi-cancer early detection test identifies cancers signals that currently lack recommended screening methods.</li><li>The company is expected to report its fourth-quarter and full-year 2025 results on February 23.</li></ul>Hims &amp; Hers Health, Inc. (HIMS) came under the spotlight on Wednesday after the company unveiled a blood test to detect signals for more than 50 types of cancer, often before symptoms appear.Called the Hims &amp; Hers Multi-Cancer Test by Galleri, the test uses the company’s digital platform with GRAIL’s advanced cancer screening technology. The multi-cancer early detection test identifies shared cancer signals, including those for cancers that currently lack recommended screening methods.“GRAIL believes making validated MCED tests available as a complement to recommended cancer screenings can help to increase cancer detection before cancers spread, improve outcomes, and enable this breakthrough technology to be available to more people,” said&nbsp; Josh Ofman, President at GRAIL.<a href="https://stocktwits.com/symbol/HIMS">HIMS</a> was among the top trending tickers on Stocktwits while the shares edged 1% lower after the opening bell.<h2 class="st-heading-2">Stocktwits Users Reaction</h2>Despite the intraday drop, retail sentiment on Stocktwits turned 'bullish' from 'neutral' a day earlier, amid 'high' message volumes.<img src="https://news.stocktwits-cdn.com/HIMS_jpg_766ade307d.webp" alt="HIMS.jpg">One user said the news could become a big growth catalyst for the company.<stembedurl>https://stocktwits.com/TheBullishTrade/message/643934180</stembedurl>Another user said "preventative healthcare is the future."<stembedurl>https://stocktwits.com/TheBullishTrade/message/643934180</stembedurl>The stock has been under selling pressure lately, slumping more than 25% so far this year.Hims &amp; Hers Health is expected to report its fourth-quarter (Q4) and full-year 2025 financial results on February 23. During its Q3 report, the company had guided FY2025 revenue between $2.335 billion and $2.355 billion and adjusted earnings guidance between $307 million and $317 million.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/why-bsx-stock-falling-today/cZbS6QuR4Z8">BSX Stock Tumbles Pre-Market On Softer 2026 Sales Growth Forecast</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a smartphone displays the logo of Hims & Hers Health in front of a screen showing the company's stock market chart. (Photo illustration by Cheng Xin/Getty Images)

HIMS Stock Garners Retail Buzz After Launching New Multi-Cancer Detection Test

The company unveiled a blood test to detect signals for more than 50 types of cancer.

HIMZ
Defiance Daily Target 2X Long HIMS ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest HIMZ News

HIMZDefiance Daily Target 2X Long HIMS ETF